hepatic sterols and the activity of liver microsomal 3-hydroxy-3-methylglutaryl-CoA reductase. 2. The stimulation was observed at short time-intervals with a maximum at 4h and was progretsive with incsg concentrations of noradrenaline. 3. Protein synthesis de novo was a necessary factor for the effect. 4. The stimulatory effect was not mediated through the adrenergic receptors, but appears to involve a direct action of the hormone within the hepatocyte.
Several hormones are known to influence the biogenesis of sterols in the liver and the activity of 3-hydroxy-3-methylglutaryl-CoA reductase (EC 1.1.1.34), the rate-determining step in the pathway. An increase was observed after injection of pharmacological doses of insulin (Nepokroeff et al., 1974) , glucagon (Huber et al., 1973) or tri-iodothyronine (Ness et al., 1973) . In experiments with rat liver slices, Bortz (1968) found that injection of noradrenaline resulted in a twofold stimulation of cholesterol biogenesis from [1-14C] acetate, with a lag period of 12h. Noradrenaline did not increase the depressed activity of hydroxymethylglutaryl-CoA reductase in adrenalectomized rats (Edwards, 1973) . Adrenaline and noradrenaline have--been shown to incease the rate of incorporation of [1-14C] acetate into non-saponifiable lipids and the activity of hydroxymethylglutaryl-CoA reductase in rat hepatocytes (Edwards, 1975) .
A study of the efft of noradrenaline on hepatic cholesterol biogenesis and the activity of hydroxymethylglutaryl-CoA reductase in rat liver is reported here. The effect of different adrenergic-blocking agents on the stimulation of noradrenaline has been studied with a -view to understanding the nature of this stimulatory effect. Thberesults indicate that the effect of noradrena-line is a result of direct action of the molecule within the cell and may not involve the mediation of either a-or fI-adrenergic receptors, nor of cyclic AMP.
Materialsand Methods Chemicals
[l-14C]Acetate (specific radioactivity, 49mCi/ mmol) was obtained from Bhabha Atomic Research Centre, Bombay, India. 3-Hydroxy-3-methyIf3-14C]-glutarate (specific radioactivity, 7.7mCi/pmmol) was VQ,I; 16 purchased from New England Nuclear Corp., Boston, MA, U.S.A. After suitable dilution with nonradioactive compound, the glutarate was converted into its anhydride, and then into -the CoA derivative as described by Louw et al. (1969) . The specific radioactivity of 3-hydroxy-3-methylglutaryl- The radioactive compounds were injected intraperitoneally, 30min before the animals were killed by cervical dislocation. The procedure for isolation of non-saponifiable lipids and their fractionation on 5 % deactivated alumina was as described by Subba Rao et al. (1976) Assay ofhydroxymethylglutaryl-CoA reductase Rats were killed by cervical dislocation, and the livers were excised and placed in an ice-cold solution containing 30mM-EDTA, 70mM-NaCI, lOmM-dithiothreitol and 50mM-potassium phosphate buffer (pH7.4), minced and homogenized (5ml/g of liver) in a Potter-Elvehjem-type glass homogenizer. Microsomal fractions were prepared by the method of Shapiro & Rodwell (1971) . The microsomal pellet was resuspended in the same homogenization medium and the suspension was used as the enzyme source. Assay of the enzyme was carried out by the micro-method of Shapiro et al. (1974) . The enzyme (about 0.3mg of microsomal protein) was pre-incubated for 5min at 37°C with 4.5,umol of glucose 6-phosphate, 450nmol of NADP+ and 1 unit of glucose 6-phosphate dehydrogenase in a total volume of 100lul. The reaction was started by adding hydroxymethyl[3-"C]glutaryl-CoA and stopped by the addition of 30,u1 of lOM-HCI. Non-radioactive mevalonic acid (0.5mg) was added and the mixture was incubated for a further 30min at 37°C for complete lactonization of the mevalonic acid. The mevalonolactone was separated on silicagel t.l.c. plates and the radioactivity determined as described previously (Subba Rao et al., 1976 These results suggest that the effect is at a premevalonate site, and probably on the enzyme hydroxymethylglutaryl-CoA reductase. On testing the enzyme activity in noradrenaline-treated animals, the expected increase in the activity of hydroxymethylglutaryl-CoA reductase was found (Table 1) .
Time-course ofstimulation by noradrenaline
The incorporation of [1-14C]acetate into hepatic sterols was determined at time-intervals after the administration of noradrenaline (0.2mg/rat). In each experiment, the result was compared with that of the control group, which received only 0.9 % NaCi. The stimulatory effect could be observed even 1 h after administration of noradrenaline, in contrast with the observation by Bortz (1968) , where the effect was seen only after a lag period of 12h. Bortz (1968) used a liver-slice system, whereas whole animals were used in the present studies. Maximum incorporation was obtained by 4h. Thereafter it decreased and stabilized at a value higher than that of the normal (Fig. 1) . For convenience, the 2h time-interval was chosen for other experiments.
Effect ofdifferent concentrations ofnoradrenaline
Radioactivity incorporated into hepatic sterols from [1-14C] acetate and the activity of hydroxymethylglutaryl-CoA reductase were measured 2h after the administration of different concentrations of noradrenaline. The stimulation was progressive with increasing concentrations of the hormone for both biogenesis of sterols and hydroxymethylglutaryl-CoA reductase activity (Fig. 2) 
Effect ofagents that increase endogenous noradrenaline
As these results clearly showed that exogenous noradrenaline stimulated biogenesis of cholesterol, it was ci1Wd to test the effect of agents known to increase the concentration of endogenous noradrenaline. The main pathway for degradation of catecholamines is through monoamine oxidase. Pargyline (Hellerman & Erwin, 1968) , the wellknown monoamine oxidase inhibitor which prevents the degradation of noradrenaline, and the drug Ro 4-1284, which increases the concentration of noradrenaline at the site by enhancing the rate of release (Pletscher et al., 1962) , were used for this set of experiments. Results in Table 3 show that both the compounds tested effectively stimulated hepatic sterol biogenesis from acetate. When pargyline and noradrenaline were given together, there was no further stimulation over that obtained with pargyline alone. It is therefore possible that the endogenous amine concentration would have reached saturation in the presence of pargyline.
Effect of adrenergic-blocking agents
Effects of catecholamines are known to be mediated through the two adrenergic membrane receptors (o-and fl-receptors) described in various tissues, including the liver (Hornbrook, 1970) . CAtecholamines are known to combine with either or both of these receptors on the cell membrane, resulting in specific cellular responses. Several pharmacological agents specifically inhibit responses to catecholamines. To discover if any of the adrenergic receptors are involved in the stimulation of sterol biogenesis by noradrenaline, a set of experiments using specific blocking agents was designed. The adrenergic-blocking agents are known to decrease the rate ofrelease of noradrenaline from the nerve granules and inhibit the ATP-dependent uptake of the hormone (von Euler & Lishajko, 1966) . Phenoxybenzamine, an a-adrenergic-blocking agent, and propranolol and practalol, both fl-adrenergicblocking agents, were used. The blocking agents were given to the animals 10min before injection of noradrenaline into the experimental group. The incorporation of [1-14C] acetate into sterols and the activity of hydroxymethylglutaryl-CoA reductase in the liver were determined. Table 4 shows that neither the a-nor the fl-adrenergic-blocking agents could abolish the stimulatory effect ofnoradrenaline. These results suggest that the stimulation by noradrenaline of hepatic biogenesis of sterols is not mediated by either a-or ,B-adrenergic receptors.
Effect ofdibutyryl cyclic AMP
The results obtained from studies in vivo and in vitro of sterol biogenesis with cyclic AMP are contradictory. Bricker & Levey (1972) Table 4 . Effect ofadrenergic-blocking agents on the incorporation of [1-_4Clacetate into hepatic sterols and hydroxymethylglutaryl-CoA reductase activity in rats treated with noradrenaline Phenoxybenzamine (2mg/rat), practalol (5mg/rat) and propranolol (2.5mg/rat) were given intraperitoneally as a suspension in 0.9% NaCl 10min before injecting noradrenaline (0.2mg/rat). Animals were killed after 2h. [1-14C]-Acetate (lOuCi/rat) was given as an intraperitoneal injection 30min before killing. Radioactivity incorporated into hepatic sterols and the activity of hydroxymethylglutaryl-CoA reductase were determiined as described in the text. The values are means ± S.E.M. for four or more animals in each group.
Compound Experiment injected this compound was without effect on sterol biogenesis in fed animals in vivo. Theophylline, which is known to increase cyclic AMP by inhibiting phosphodiesterase (Sutherland et al., 1968) , also had no effect (Table 5 ). The possibility of cyclic AMP being a mediator in the stimulatory effect of noradrenaline seems remote, in view of the negative results in the experiments with the adrenergicVol. 162 blocking agents, theophylline and exogenous cyclic AMP.
Effect ofdihydroxyphenylserine
The above results suggested that the stimulatory action of noradrenaline could not be mediated through the adrenergic receptors or cyclic AMP, and (Dairman et al., 1972) on this compound, the concentration of noradrenaline increased within the cells when administered to animals (McCann et al., 1972) . As expected, the compound stimulated both the incorporation of [1-_4C]acetate into hepatic sterols and the activity of hydroxymethylglutaryl-CoA reductase, at two concentrations tested (Table 6) . These results further support the direct mode ofaction of noradrenaline molecules within the hepatocyte, unconnected with the adrenergic membrane receptors or the adenylate cyclase system, with respect to biogenesis of sterols.
Discussion
The foregoing experiments show that administration of noradrenaline stimulates hepatic biogenesis of sterols and hydroxymethylglutaryl-CoA reductase activity at shorter time-intervals than those observed by Bortz (1968) . Maximum stimulation was observed after 12h in his experiments with liver slices, in contrast with 4h in the studies reported here.
On the basis of the present knowledge of the nature of action of noradrenaline, two alternatives could be considered for its stimulation of sterol biogenesis: either action at the cell-membrane level, involving specific adrenergic receptors (a or /3), or a direct action at the intracellular level. The mechanism involving a membrane receptor is ruled out, as the adrenergic-blocking agents failed to prevent the stimulation of sterol biogenesis by the hormone. As the agents that increase endogenous noradrenaline, and more specifically 3,4-dihydroxyphenylserine, which gives rise to noradrenaline within the cell cytosol, elicited the same response as the hormone, the second alternative seems likely. A similar case has been reported for gluconeogenesis and glycogenolysis, where the action of the hormone persisted, even when the enhancement of cyclic AMP concentration was abolished by the adrenergic-blocking agents (Saitoh & Michio, 1976) Catecholamines are known to enhance lipolysis in intact rats, resulting in increased concentrations of free fatty acids in the liver. It was proposed by Bortz (1973) that the effects of catecholamines are mediated by free fatty acids. But from the experiments with rat hepatocytes, Edwards (1975) concluded that the above hypothesis may not be valid, as an increased supply of free fatty acids is impossible with isolated hepatocytes, and that the effect of catecholamines must be a direct one within the cells. Results of the present studies with adrenergic-blocking agents, cyclic AMP and 3,4-dihydroxyphenylserine, all favour the direct mode of action of noradrenaline within the hepatocyte.
